← SynDRA
Ku-0063794
SynDRA canonical compound SYN0021289 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | MTOR |
|---|
| Mechanism of action | MTOR inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
Cross-references
Synonyms
- KU0063794
- Ku 63794
- Ku63794
- CHEBI:85572
- RefChem:794371
- DTXCID00162273
- MFCD22666594
- UNII-81HJG228AB
- MLS006011007
- SCHEMBL290211
- GTPL9360
- orb1305428
- SCHEMBL29350060
- SCHEMBL29454796
- EX-A045
- BDBM50310989
- HB2250
- s1226
- AKOS005145564
- CCG-264870
- CS-0065
- EX-5106
- FK65052
- SDCCGSBI-0654360.P001
- NCGC00250396-01
- NCGC00250396-11
- AC-31515
- AS-16210
- HY-50710
- SMR004702805
- SW220188-1
- F17370
- F050743
- K800000
- KU 0063794, >=98% (HPLC)
- BRD-K67566344-001-01-8
- BRD-K67566344-001-07-5
- BRD-K67566344-001-08-3
Look up Ku-0063794 in the interactive SynDRA portal →